Shopping Cart
- Remove All
 
Your shopping cart is currently empty
L-(+)-Arabinose selectively inhibits intestinal sucrase in a non-competitive manner, thereby preventing glucose elevation induced by sucrose intake.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 g | $30 | In Stock | |
| 2 g | $40 | In Stock | |
| 5 g | $64 | In Stock | 
| Description | L-(+)-Arabinose selectively inhibits intestinal sucrase in a non-competitive manner, thereby preventing glucose elevation induced by sucrose intake.  | 
| In vitro | L-(+)-Arabinose is associated with ribose-5-phosphate isomerase deficiency, an inborn metabolic error[1]. It selectively inhibits intestinal sucrase in a noncompetitive manner, thereby suppressing the increase in plasma glucose following sucrose consumption[1].  | 
| In vivo | L-(+)-Arabinose feeding reduced the weights of epididymal adipose tissue in rats. Moreover, plasma insulin and triacylglycerol concentrations were significantly reduced by dietary L-(+)-Arabinose[1]. L-(+)-Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice[2].  | 
| Molecular Weight | 150.13 | 
| Formula | C5H10O5 | 
| Cas No. | 5328-37-0 | 
| Smiles | [C@H]([C@H](CO)O)([C@H](C=O)O)O | 
| Relative Density. | 1.31g/cm3 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (399.65 mM), Sonication is recommended.  H2O: 400 mg/mL (2664.36 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (6.66 mM), Sonication is recommended.  Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table  | ||||||||||||||||||||||||||||||||||||
DMSO/H2O 
  | ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.